Related Experiment Video
Updated: Mar 25, 2026

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
60 YEARS OF POMC: Lipotropin and beta-endorphin: a perspective
1Department of EndocrinologyWilliam Harvey Research Institute, London, UK derekgsmyth@live.co.uk.
Early chromatography techniques enabled the study of amino acid structures, revealing the crucial link between molecular structure and function. This foundational work transformed our understanding of biologically active molecules and brain signaling.
Area of Science:
- Biochemistry
- Molecular Biology
- Neuroscience
Background:
- Early advancements in chromatography, including paper chromatography and column analysis for amino acids, laid the groundwork for determining complex molecular structures.
- Pioneering work by scientists like A.J.P. Martin, Moore, and Stein enabled the separation and quantification of amino acids.
Observation:
- The ability to determine molecular structure revealed the fundamental relationship between a molecule's structure and its biological function.
- Interdisciplinary collaboration between chemists and biologists accelerated progress in fields like molecular endocrinology.
Findings:
- Nobel laureates like Archibald Martin, Rodney Porter, Fred Sanger, and Vincent du Vigneaud recognized the future importance of structure determination.
- The study of structures such as β-endorphin and enkephalin demonstrated their significant roles in opiate activity.
Implications:
- Structure determination has revolutionized the understanding of chemical transmission in the brain.
- This approach has led to transformative insights in molecular endocrinology and other biologically active molecule studies.
Related Concept Videos
Opioid Receptors: Overview
Regulation of Food Intake
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Analgesia and Pain Management
Opioid Analgesics: Morphine and Other Natural Cogeners
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...

